ABOUT US

The team

EPILAB_Maurice.jpeg

Maurice Lubetzki

CEO

Entrepreneur, Engineer

Clément.jpg

Clément Dubois

CTO

Entrepreneur, Engineer

Murielle.jpg

Murielle Rochelet

CSO, inventor

PhD in Electrochemistry

Elodie .jpg

Elodie Barbier

Research scientist, Inventor

PhD in Microbiology

JB_210602_00013_Epilab - B&W.jpeg

Quentin Poulard

Head of prototyping  
Engineer

Manon.jpg

Manon Giraud

Head of R&D

PhD in Microtechnologies, Engineer

A complementary team driven by a same goal : build the best screening tool for tuberculosis and diagnose the 4 million people undetected each year !

Join epilab 

hiring.png



Epilab is recruiting a senior R&D manager and an R&D assistant, apply below!
We are also looking for motivated and talented people to join our product team!


Get in touch and we will see what you can bring to epilab.



 

Théo_edited.jpg

Théo Fouchet

Doctorate student 

Microbiologist, Engineer

Sup'Biotech_Raphaëlle_Paounov_promo2021_002 (1)_edited.jpg

Raphaëlle Paounov

R&D scientist
Biomedical engineer

Diane_edited.jpg

Diane Dehiles

Head of regulatory affairs

Biomedical engineer 

Scientific Board

Lucas.jpg

Dr. Lucas Esuh Esong

Member of the PNLT (National program to fight tuberculosis) in Cameroon; consultant for WHO on tuberculosis in Africa and founder of the Always Care Foundation, which promotes access to care and education in underprivileged communities.

Dr. Esuh Esong is well acquainted with the problems associated with field diagnosis and is currently helping EpiLAB organise clinical studies in Central and Sub-Saharan Africa.

Julien.jpg

Julien Reboud, PhD

Dr Julien Reboud is a Reader in Biomedical Engineering at the University of Glasgow and has an extensive track record in developing and integrating low cost microfluidic systems for measurement of multiple disease states, including in low-resource settings.

After his PhD on new microfluidic technologies for drug screening, Julien worked on new biosensors for medical diagnostics. He then got passionate about translation of new technologies into clinical use and has been awared the RAEng ERA Entrepreneurship Prize (2013). He is currently a co-founder of Acu-Flow Ltd, which won the Scottish Edge in 2019.

Laurent.jpg

Dr. Laurent Raskine

Expert in tuberculosis and international operations for Mérieux Foundation.
      His extensive experience in the field and his vast knowledge about the disease disease make him uniquely positioned to guide EpiLAB through scientific research and product development. Laurent Raskine has already set up laboratories and deployed tests in the countries where EpiLAB plans to establish operations, particularly in Africa.  

Origin of Epilab

Learn more about our project's creation !

When ?

During the first lockdown in March 2020

Why ?

Clément Dubois is interested in the valorisation of French technologies

How ?

He connected with several SATT (technology acceleration and transfer company).From SATT Sayens, the EDMYC process "new portable and easy to use kit for tuberculosis diagnosis" hooked his attention.

Who ?

With the two technology inventors, Murielle Rochelet, Elodie Barbier, and Maurice Lubetzki, former entrepreneur, they decided to take over the EDMYC patent and created EpiLAB.

Achievements

viva.jpg

Meeting Frédérique Vidal, at Viva Technology event

June 2021

​Viva technology, Europe's biggest startup and tech event, was organised in june 2021 in Paris. Epilab had the opportunity to present its solution on a stand and meet several potential partners. 

Special thanks to Frederic Vidal, Minister of Higher Education, Research and Innovation, to whom we presented the EpiLAB solution.

france biotech.PNG
biotech fr.PNG

Interview with Epilab at France biotech

June 2021

France Biotech is the French trade association of biotechnology companies. Its primary mission is to support the development of this industry in France.
Epilab was the subject of the 5th episode of its "Pépites Healthtech" series where France Biotech present promising start-ups. 

jj.jpg

Epilab in Les Echos

February 2021

Article in Les Echos, looking back at the beginnings of the start-up and the collaboration with SATT Sayens. Sayens has overseen the maturation of the innovation based on the electrochemical detection of tuberculosis, and now becomes a minor shareholder of the company to help deploy this rapid diagnostic kit on a global scale.

image deeptech connect.jfif

Deeptech Connect event in Paris 

November 2021

Epilab had the opportunity to exchange with the Deeptech ecosystem during the Deeptech Connect. A very interesting day where multiple actors from multiples domains, related to deeptech, gathered. 

logo Cerba.jpg

Epilab joins Cerba Healthcare's virtual incubator

November 2021

By joining the Virtual Incubator of Cerba HealthCare Group, already widely established in Africa, EpiLAB will be able to accelerate the development of its test and its widespread use. The collaboration with Cerba HealthCare will allow Epilab to propose a product as close as possible to the needs of the field, in order to facilitate its adoption by healthcare professionals and optimize its integration into new patient pathways. 

demoday.jfif

X-Up Demoday

December 2021

On December 14th was held 13th DemoDay 13 the X-Novation Center from École Polytechnique. EpiLAB had the opportunity to pitch in front of a selected panel of investors and mentors.

Special thanks to the whole ecosystem for the amazing support!

deeptech.jpg

Epilab receives BPI DeepTech label

January 2022

Epilab officially labeled Deeptech by Bpifrance! 
One more step towards the deployment of Epilab portable screening kit.

JB_210602_00018_Epilab.jpeg

1M€ seed to develop Epilab kit 

February 2021

Epilab raises €1 million to develop its portable, simple and rapid tuberculosis diagnostic kit. This kit will be the first to answer the international's demand for a such a screening tool, and will be deployed in West Africa. 

adsasd.png

Epilab joins La French Tech Paris Saclay community

February 2021

French Tech Paris-Saclay represents the interests of a community of start-ups, scaleups and project leaders in the Paris-Saclay, Yvelines and Essonne area.

ads.png

Epilab is selected by SNITEM for the 6th "day of the innovative Startup of the medical device"!

January 2021

SNITEM (Syndicat National de l'Industrie des Technologies Médicales) is the leading professional organisation representing most of the Medical Devices and Health ICT industryies. It federates more than 500 companies.

sda.png

Epilab is labeled DeepTech Pioneer by Hello Tomorrow

November 2020

Hello tomorrow is a mission-driven global organisation that aims to accelerate the transfer of deep technologies to solve some of our most pressing industrial, environmental and societal challenges. For its global summit, they selects start-ups that are game-changers developing cutting-edge technology to bring positive change to our planet, society and industries : DeepTech Pioneers.

Our partners

jj.png

Epilab joins X-up at Ecole Polytechnique

August 2020

EpiLAB is selected to join the famous Ecole Polytechnique's incubator.

l.jpg

Participation in two challenges

October 2020

EpilAB wins the Prix de l'ingénierie du futur by SYNTEC (https://www.youtube.com/watch?v=k3a0yH9jWDg&ab_channel=Concepteursd%27Avenirs) and reaches the final of the challenge of Centrale Schools

jj.jpg

Beginning of The Project

March 2020

The first meeting between Clément, Maurice, Murielle and Elodie took place in March 2020. Everyone quickly connected and wished to collaborate and put each skill in contribution to develop the portable kit.